Rothendler James A, Rose Adam J, Reisman Joel I, Berlowitz Dan R, Kazis Lewis E
Am J Cardiovasc Dis. 2012;2(3):184-91. Epub 2012 Jul 25.
While developed for managing individuals with atrial fibrillation, risk stratification schemes for stroke, such as CHADS2, may be useful in population-based studies, including those assessing process of care. We investigated how certain decisions in identifying diagnoses from administrative data affect the apparent prevalence of CHADS2-associated diagnoses and distribution of scores. Two sets of ICD-9 codes (more restrictive/ more inclusive) were defined for each CHADS2-associated diagnosis. For stroke/transient ischemic attack (TIA), the more restrictive set was applied to only inpatient data. We varied the number of years (1-3) in searching for relevant codes, and, except for stroke/TIA, the number of instances (1 vs. 2) that diagnoses were required to appear. The impact of choices on apparent disease prevalence varied by type of choice and condition, but was often substantial. Choices resulting in substantial changes in prevalence also tended to be associated with more substantial effects on the distribution of CHADS2 scores.
虽然是为管理房颤患者而制定的,但诸如CHADS2等中风风险分层方案在基于人群的研究中可能有用,包括那些评估医疗过程的研究。我们调查了从行政数据中识别诊断的某些决策如何影响CHADS2相关诊断的表观患病率和分数分布。为每个CHADS2相关诊断定义了两组ICD - 9代码(更严格/更宽泛)。对于中风/短暂性脑缺血发作(TIA),更严格的一组仅应用于住院患者数据。我们改变了搜索相关代码的年份数(1 - 3年),并且除了中风/TIA外,改变了诊断所需出现的实例数(1次与2次)。选择对表观疾病患病率的影响因选择类型和疾病状况而异,但通常很大。导致患病率大幅变化的选择也往往对CHADS2分数分布有更大影响。